Chattem, Inc.

SAN FRANCISCO, June 20, 2022 /PRNewswire/ -- The global pharmacovigilance and drug safety software market size is anticipated to reach USD 17.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 10.5% from 2022 to 2030. The key factors driving the market growth include the increasing need to track and manage adverse drug reactions (ADR), comply with regulatory norms, increase adoption by end-users, interoperability, and product upgrades by key companies. Key Industry Insights & Findings from the report: The market was valued at USD 6.7 billion in 2021 and is expected to expand at a CAGR of 10.5% during the forecast period. By functionality, the signal management segment held the largest revenue share in 2021. This growth is driven by the increasing use of machine learning and AI in signal detection and reporting. Based on delivery mode, the on-demand segment dominated the market in 2021. This is owing to the greater flexibility offered by an on-demand software in terms of price, functionality, and scalability. Based on end-use, the CROs and BPO segments are slated to witness lucrative growth owing to increasing adoption by outsourcing companies to curb healthcare costs. By region, North America dominated the market in 2021 while the APAC market is anticipated to grow the fastest in the coming years. Asian countries, especially India and China, are also expected to observe remarkable growth in the coming years. The market is relatively competitive owing to the presence of global multinational players. It is also consolidated to a certain extent with large multinational companies holding a notable share of the market. Read 130-page market research report, " Pharmacovigilance And Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode (On Premise, On Demand), By End-use, By Region, And Segment Forecasts, 2022 - 2030 ", published by Grand View Research. Pharmacovigilance and Drug Safety Software Market Growth & Trends Various end-users such as pharmaceutical, and biotechnology companies, are adopting pharmacovigilance and drug safety software for cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in the short as well as long term. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes. This is expected to fuel market growth. Pharmacovigilance and drug safety software vendors, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs. These vendors are also incorporating integrated technologies such as electronic data capture, AI, and interoperability, among others to enhance their offerings. Moreover, the combined pressures of volume, cost, and heightened demand for analytics are propelling industry stakeholders to adopt advanced technology to support their pharmacovigilance activities. Also, the fact that service providers are now operating via a flexible and variable pricing structure and achieving operational excellence through constant product updates is expected to boost usage rates over the forecast period. Pharmacovigilance and Drug Safety Software Market Segmentation Grand View Research has segmented the global pharmacovigilance and drug safety software market based on functionality, delivery mode, end-use, and region: Pharmacovigilance and Drug Safety Software Market - Functionality Outlook (Revenue, USD Million, 2017 - 2030) Case Processing Signal Management Safety Metrics & Others Pharmacovigilance and Drug Safety Software Market - Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030) On-Premise On-Demand Pharmacovigilance and Drug Safety Software Market - End-use Outlook (Revenue, USD Million, 2017 - 2030) Pharma & Biotech Companies CRO BPO Others Pharmacovigilance and Drug Safety Software Market - Regional Outlook (Revenue, USD Million, 2017 - 2030) North America U.S. Canada Europe Germany U.K. France Italy Spain Asia Pacific China India Japan Australia South Korea Latin America Brazil Mexico Argentina MEA South Africa Saudi Arabia List of Key Players in the Pharmacovigilance and Drug Safety Software Market IQVIA Accenture Cognizant Laboratory Corporation of America Holdings IBM ArisGlobal ICON Plc. Capgemini Oracle Parexel International Corporation Check out more related studies published by Grand View Research: Clinical Trials Matching Software Market - The global clinical trials matching software market size is expected to reach USD 396.1 million by 2030, based on a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 13.8% from 2022 to 2030. The significant increase in the number of ongoing clinical trials is likely to drive the market. In addition, the growing adoption of the clinical trial matching software catering to the clinical trials, along with the increased demand for virtual trials and automation in the healthcare sector are some of the key factors contributing to the market growth. Medical Image Analysis Software Market - The global medical image analysis software market size is expected to reach USD 5.49 billion, expanding at a CAGR of 7.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of chronic diseases creates demand for effective diagnostics solutions, which spurs the demand for medical image analysis software. The high growth is majorly attributed to a rise in the usage and uptake of image analysis solutions for diagnosis ring. Patient Safety And Risk Management Software Market - The global patient safety and risk management software market size is expected to reach USD 3.1 billion by 2027, expanding at a CAGR of 11.0%, according to a new report by Grand View Research, Inc. The increasing need for efficient patient safety and risk assessment solutions to increase the efficiency of the healthcare providers and rising government initiatives to promote healthcare IT and improve the healthcare infrastructure are the key factors driving the market growth. Browse through Grand View Research's Healthcare IT Industry Research Reports. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: Grand View Compass | Astra ESG Solutions Follow Us: LinkedIn | Twitter Logo: SOURCE Grand View Research, Inc.

Dublin, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The "APAC Hand Sanitizer Market, by Product Type (Gel, Liquid, Foam and Spray), by End User (Hospitals, Households and Others (Restaurants & Hotels, Schools, etc.), by Distribution Channel, by Country, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. The APAC Hand Sanitizer Market is projected to witness a CAGR of 17% during 2021 - 2025 due to rising awareness about healthy lifestyle & wellness, spread of COVID-19, shifting consumer preference towards convenient hygiene products, increasing product variants, and rising disposable income across the region. Moreover, strong marketing activities by leading brands, increase in urban population, etc., are some of the other drivers of the APAC Hand Sanitizer Market. Also, increasing usage of hand sanitizers while travelling, when soap and water are not available, is boosting overall consumption of hand sanitizers. The APAC Hand Sanitizer Market is categorized into By Product Type, By Distribution Channel, By End-User, By Country and By Company. In terms of Product Type, the market is categorized into Gel, Liquid, Foam and Spray, among which Gel based segment is expected to continue its market dominance during the forecast period as it gets easily absorbed into the skin while killing most of the bacteria and viruses. In terms of distribution segmentation, the market is categorized into Pharmacy Stores, Supermarkets/Hypermarkets, Departmental/Convenience Stores and Others. Supermarket/Hypermarkets segment captured the largest market share in 2019 and the segment is anticipated to lead the market throughout the forecast period as growing number of consumer prefer to shop from supermarkets for easy availability of different products under one roof. China dominated APAC hand sanitizer market in 2019, followed by Japan. Both the countries are expected to continue their dominance in the region's hand sanitizer market due to large population, high consumer awareness, comparatively higher income levels and rising consumption of hand sanitizer among young adults. Few of the major players operating in the APAC Hand Sanitizer Market include Reckitt Benckiser (India) Ltd., Hindustan Unilever Ltd., 3M Company, Himalaya Drug Company Pvt. Ltd., ITC Ltd., among others. Years considered for this report: Historical Years: 2015 - 2018 Base Year: 2019 Estimated Year: 2020E Forecast Period: 2021F - 2025F Key Topics Covered: 1. Product Overview 2. Research Methodology 3. Executive Summary 4. Voice of Customer 5. Asia Pacific Hand Sanitizer Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Product Type (Gel, Liquid, Spray and Foam) 5.2.2. By Distribution Channel (Pharmacy Stores, Supermarkets/Hypermarkets, Departmental/Convenience Stores and Others) 5.2.3. By End User (Household, Hospitals and Others) 5.2.4. By Country 5.2.5. By Company (2019) 5.3. Market Attractiveness Index 5.4. Pricing Analysis 6. China Hand Sanitizer Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Product Type 6.2.2. By Distribution Channel 6.2.3. By End User 6.3. Pricing Analysis 7. India Hand Sanitizer Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Product Type 7.2.2. By Distribution Channel 7.2.3. By End User 7.3. Pricing Analysis 6. Japan Hand Sanitizer Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Product Type 8.2.2. By Distribution Channel 8.2.3. By End User 8.3. Pricing Analysis 9. Australia Hand Sanitizer Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Product Type 9.2.2. By Distribution Channel 9.2.3. By End User 9.3. Pricing Analysis 10. South Korea Hand Sanitizer Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Product Type 10.2.2. By Distribution Channel 10.2.3. By End User 10.3. Pricing Analysis 11. Indonesia Hand Sanitizer Market Outlook 11.1. Market Size & Forecast 11.1.1. By Value 11.2. Market Share & Forecast 11.2.1. By Product Type 11.2.2. By Distribution Channel 11.2.3. By End User 11.3. Pricing Analysis 12. Taiwan Hand Sanitizer Market Outlook 12.1. Market Size & Forecast 12.1.1. By Value 12.2. Market Share & Forecast 12.2.1. By Product Type 12.2.2. By Distribution Channel 12.2.3. By End User 12.3. Pricing Analysis 13. Malaysia Hand Sanitizer Market Outlook 13.1. Market Size & Forecast 13.1.1. By Value 13.2. Market Share & Forecast 13.2.1. By Product Type 13.2.2. By Distribution Channel 13.2.3. By End User 13.3. Pricing Analysis 14. Singapore Hand Sanitizer Market Outlook 14.1. Market Size & Forecast 14.1.1. By Value 14.2. Market Share & Forecast 14.2.1. By Product Type 14.2.2. By Distribution Channel 14.2.3. By End User 14.3. Pricing Analysis 15. Thailand Hand Sanitizer Market Outlook 15.1. Market Size & Forecast 15.1.1. By Value 15.2. Market Share & Forecast 15.2.1. By Product Type 15.2.2. By Distribution Channel 15.2.3. By End User 15.3. Pricing Analysis 16. Market Dynamics 16.1. Drivers 16.2. Challenges 17. Value Chain Analysis 18. Market Trends & Developments 19. Competitive Landscape 19.1. Players Profiled (Leading Companies) 19.1.1. Reckitt Benckiser Group plc 19.1.2. GOJO Industries, Inc. 19.1.3. The Himalaya Drug Company 19.1.4. Chattem, Inc. 19.1.5. ITC Limited 19.1.6. The Procter & Gamble Company 19.1.7. Unilever Group 19.1.8. Ecolab 19.1.9. Kutol Products Co Inc 19.1.10. Henkel AG & Co. KGaA 20. Strategic Recommendations For more information about this report visit Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900